Visa Inc. – Consensus Indicates Potential 30.2% Upside

DirectorsTalk Interviews

Visa Inc. with ticker code (V) now have 37 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 296 and 220 calculating the average target price we see 261.34. Given that the stocks previous close was at 200.71 this is indicating there is a potential upside of 30.2%. The 50 day moving average now sits at 207.77 and the 200 day moving average is 210.2. The company has a market capitalisation of $422,979m. Find out more information at: https://usa.visa.com

The potential market cap would be $550,751m based on the market concensus.

Visa Inc. operates as a payments technology company worldwide. The company facilitates digital payments among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. In addition, the company offers card products, platforms, and value-added services. It provides its services under the Visa, Visa Electron, Interlink, VPAY, and PLUS brands. Visa Inc. has a strategic agreement with Ooredoo to provide an enhanced payment experience for Visa cardholders and Ooredoo customers in Qatar. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.

Share on:

Latest Company News

Aptamer Group signs first licensing deal with Twist Bioscience

Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products.

PPHE Hotel Group refinances Park Plaza Victoria London

PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026.

Greggs Plc appoints Richard Smothers as Non-Executive Director

Greggs plc has announced the appointment of Richard Smothers as an independent Non-Executive Director, effective from 1 February 2026.

Hollywood Bowl Group reports FY2025 results with revenue growth

Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue and adjusted EBITDA.

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy.

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.

    Search

    Search